Chris Lehman’s Post

July 11 and 12, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics Merck’s $1.3 Billion Acquisition of EyeBio J&J’s $1.25 Billion Acquisition of Yellow Jersey IDEAYA’s $302 Million Public Offering HepaRegeniX’s $16 Million Series C Link’s $4 Million Asset Sale

July 09 and 10, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics Flagship’s $3.6 Billion Fund Raise Altos’s $177 Million Series B SciRhom’s $68 Million Series A Amylyx’s $35 Million Acquisition of Eiger Granza’s $7 Million Seed Round ReShape’s Merger with Vyome and $5 Million Asset Sale

July 05 and 08, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics Lily’s $3.2 Billion Acquisition of Morphic Myricx’s $114 Million Series A Circle’s $54 Million Series D Virpax’s $3 Million Debt Financing

July 01 and June 28, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics Alumis’s $210 Million IPO and $40 Million Private Placement Artiva’s $100 Million IPO Savara’s $100 Million Public Offering Tonix’s $34 Million Grant Kanvas’s $13 Million Venture Financing Elicio’s $12 Million Public Offering Eynovia’s $5 Million Registered Direct Offering Tonix’s $4 Million Public Offering…More GRI Bio’s $4 Million Public Offering Aptevo’s $3 Million Public Offering Kannalife’s $2 Million Grant

June 26 and 27, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics AbbVie’s $250 Million Acquisition of Celsius Therapeutics Eliem’s Acquisition of Tenet and $120 Million Private Placement Vigil’s $40 Million Private Placement from Sanofi Coherus’s $40 Million Asset Sale KALA’s $13 Million Private Placement Holoclara’s $16 Million Series A BrainStorm’s $4 Million Registered Direct Offering Cure.Bio’s $380 Million Fund Raise Formation’s $372 Million Series D Taysha’s $75 Million Public Offering 2Seventy’s $40 Million Asset Sale Insud’s $45 Million Acquisition of Agile Auguine’s $18 Million Series A1 DiaMedica’s $12 Million Private Placement Well’s $10 Million Series C CNS’s $1 Million Registered Direct Offering…More Tonix’s Public Offering

June 24 and 25, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics Zealand’s $900 Million Registered Direct ANI’s $381 Million Acquisition of Alimera Alumis’s $300 Million IPO Entrada’s $100 Million Registered Direct Offering Frontier’s $100 Million Series C Exsilio’s $82 Million Series A TwoStep’s $7 Million Seed Round NeuroBo’s $70 Million Private Placement

June 21 and 24, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics J&J’s $850 Million Acquisition of Proteologix ANI’s $381 Million Acquisition of Alimera Alumis’s $300 Million IPO Entrada’s $100 Million Registered Direct Offering NeuroBo’s $70 Million Private Placement

June 20 and 21, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics J&J’s $850 Million Acquisition of Proteologix Tectonic’s Merger with AVROBIO and $131 Million Private Placement iOnctura’s $86 Million Series B Ascentage’s $75 Million Equity Investment Forbion’s $75 Million Fund Raise āshibio’s $40 Million Seed Round and Series A Emergent’s $30 Million Asset Sale Rapafusyn’s $28 Million Series A Coeptis’s $4 Million Series A Mustang’s $3 Million Registered Direct Offering Sonnet’s $3 Million Warrant Exercise Tharimmune’s $2 Million Private Placement ProJenX’s $1 Million Grant NephroDI’s Series A

June 19 and 20, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics iOnctura’s $86 Million Series B Santhera’s $78 Million Royalty and Debt Financing Forbion’s $75 Million Fund Raise āshibio’s $40 Million Seed Round and Series A Emergent’s $30 Million Asset Sale Tharimmune’s $2 Million Private Placement

June 13 and 14, 2024 headlines from the Collabrity Report, a daily summary of financings for therapeutic biotechnology company executives and investors - www.collabrityreport.com New! Collabrity Report (CR) Analytics J.P. Morgan’s $500 Million Fund Raise Disc’s $178 Million Public Offering Santa Ana’s $168 Million Series A and B XtalPi’s $127 Million IPO Replimune’s $100 Million Private Placement InduPro’s $85 Million Series A Rezolute’s $60 Million Public Offering Gain’s $11 Million Public Offering Renovaro’s $10 Million Equity Investment Telix’s Camceled IPO